RenovoRx (RNXT)
NASDAQ:RNXT
US Market
Holding RNXT?
Track your performance easily

RenovoRx (RNXT) Financial Statements

59 Followers

RenovoRx Financial Overview

RenovoRx's market cap is currently ―. The company's EPS TTM is $-0.606; its P/E ratio is -1.72; RenovoRx is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.39M$ 2.51M$ -2.98M$ -2.33M$ 3.27M
EBITDA$ -2.39M$ 2.51M$ -2.98M$ -2.33M$ 3.27M
Net Income Common Stockholders$ -2.39M$ -1.08M$ -1.42M$ -2.33M$ 3.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 11.70M$ 4.40M$ 3.20M$ 6.00M$ 3.70M
Total Assets$ 12.00M$ 4.79M$ 3.52M$ 6.31M$ 4.56M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -11.70M$ -4.40M$ -3.20M$ -6.00M$ -3.70M
Total Liabilities$ 2.73M$ 3.02M$ 3.51M$ 5.13M$ 1.30M
Stockholders Equity$ 9.27M$ 1.77M$ 6.00K$ 1.19M$ 3.26M
Cash Flow-
Free Cash Flow$ -2.30M$ -2.20M$ -2.73M$ -2.77M$ -2.71M
Operating Cash Flow$ -2.30M$ -2.20M$ -2.73M$ -2.77M$ -2.71M
Investing Cash Flow----$ 2.03M
Financing Cash Flow$ 9.65M$ 5.42M-$ 5.00M$ 6.00K
Currency in USD

RenovoRx Earnings and Revenue History

RenovoRx Debt to Assets

RenovoRx Cash Flow

RenovoRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis